About Us
The Department of Genetic Medicine at Weill Cornell leads a dynamic and innovative translational research program, advancing diverse fields such as Genetic Therapy and Personalized Medicine.
The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing SV40 T antigen expression induces malignant proliferation of ependymal cells in transgenic mice.
| Publication Type | Academic Article |
| Authors | Perraud F, Yoshimura K, Louis B, Dalemans W, Ali-Hadji D, Schultz H, Claudepierre M, Chartier C, Danel C, Bellocq J |
| Journal | Oncogene |
| Volume | 7 |
| Issue | 5 |
| Pagination | 993-7 |
| Date Published | 05/01/1992 |
| ISSN | 0950-9232 |
| Keywords | Antigens, Viral, Tumor, Cell Transformation, Neoplastic, Ependyma, Gene Expression Regulation, Viral, Genes, Regulator, Membrane Proteins, Promoter Regions, Genetic, Simian virus 40 |
| Abstract | Transgenic mice bearing a human cystic fibrosis transmembrane conductance regulator (CFTR) promoter-SV40 T antigen fusion transgene were generated in order to localize in vivo the potential oncogenesis linked to the tissue-specific activity of the promoter for the CFTR gene. Surprisingly, the only site of tumors resulting from expression of the reporter onc gene was ependymal cells lining the brain ventricles. SV40 T antigen expression in these cells led to a consistent pathology in the first weeks of age: ependymoma and consequent hydrocephaly. Tumor-derived cell lines were established, characterized and shown to originate from SV40 T antigen-induced ependymoma. No pathological alterations were found in other organs, such as lungs and pancreas, in which cystic fibrosis is pathologically manifest in humans. Such transgenic mice and derived cell lines may represent valid models for analysing (1) the role of SV40 T antigen in ependymoma formation and (2) CFTR function in ependymal cells. |
| PubMed ID | 1373882 |